The MJ Companies|
Joe Perkins joined the MJ team in 1984 as an employee benefits consultant in our Benefits Consulting department and quickly grew to become one of the agency’s top performers. Named a principal of the firm in 2003, Joe has continued to grow and cultivate his leadership skills and technical expertise, and he is now the lead production mentor for all incoming benefits consultants within the firm.
In addition to his mentoring responsibilities, Joe provides consultation to group clients on cost-saving benefit solutions. He has a broad range of specialties, including plan design analysis, on-site clinic development and implementation, self-funding, creative pharmaceutical solutions, and consumer-driven health plans. Leveraging his extensive experience, Joe and his team aim to ensure that clients’ employee benefits strategies are aligned with their business goals and objectives as they grow and evolve.
Related Blogs
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More